S. Peter Bak, PhD
Vice President

S. Peter Bak, PhD, Vice President, Back Bay Life Science Advisors, has more than ten years of experience with a broad range of research approaches—cellular, molecular and biochemical—and fields—from immunology and infection through oncology.

At Back Bay, Dr. Bak leads a diverse portfolio of projects with a focus on liquidity planning and positioning, strategic franchise building, M&A and licensing strategy and buy side diligence. He regularly works with companies of all scales, from startup to global life science brands.

Dr. Bak’s research career in immuno-oncology began at Dartmouth Medical School (PhD, Microbiology and Immunology), where his research uncovered novel pathways of immunosuppression in ovarian cancer, and continued at MIT, as an American Cancer Society Postdoctoral Fellow at the Koch Institute of Integrative Cancer Research. At MIT, Dr. Bak focused on the development of immunotherapies for prostate cancer and led interdisciplinary projects with researchers from the departments of Biological and Chemical Engineering.

During his academic career, Dr. Bak published peer-reviewed articles on cancer vaccinology, the molecular mechanisms of myeloid-cell-mediated immune-suppression, costimulatory requirements for intertumoral T-cell activation, and immune editing within the tumor environment. He holds a degree in Biology, magna cum laude, from The College of the Holy Cross.

Recent Posts by peter

A Gutsy Combination: The Microbiome and Immuno-oncology

As science explores the effects of the microbiome on the immune system and its role in treating cancer, drug developers ... Read More

Back Bay Life Science Advisors published in STAT News

“The question of how to best develop and commercialize novel antibiotics while at the same time creating a return for ... Read More

Back Bay Report on Neoantigen-Based Cancer Immunotherapy

Immuno-oncology, a promise for decades, has burst forth as a clear means to advance patient care and spur research and ... Read More